Raymond James Financial Inc. purchased a new position in Cronos Group Inc. (NASDAQ:CRON - Free Report) in the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund purchased 317,418 shares of the company's stock, valued at approximately $641,000. Raymond James Financial Inc. owned about 0.08% of Cronos Group as of its most recent SEC filing.
Other large investors have also made changes to their positions in the company. Thompson Davis & CO. Inc. acquired a new stake in shares of Cronos Group during the 4th quarter worth $29,000. SBI Securities Co. Ltd. purchased a new position in Cronos Group in the 4th quarter worth approximately $30,000. Jones Financial Companies Lllp lifted its position in shares of Cronos Group by 64.5% during the fourth quarter. Jones Financial Companies Lllp now owns 16,623 shares of the company's stock worth $34,000 after purchasing an additional 6,520 shares in the last quarter. Headlands Technologies LLC increased its position in shares of Cronos Group by 904.4% during the fourth quarter. Headlands Technologies LLC now owns 28,917 shares of the company's stock worth $58,000 after acquiring an additional 26,038 shares during the last quarter. Finally, Arrowstreet Capital Limited Partnership purchased a new position in Cronos Group in the fourth quarter valued at about $76,000. Institutional investors and hedge funds own 8.71% of the company's stock.
Cronos Group Price Performance
Shares of NASDAQ:CRON traded up $0.01 during midday trading on Tuesday, reaching $2.06. The company had a trading volume of 1,182,718 shares, compared to its average volume of 1,334,369. The stock has a market capitalization of $792.01 million, a P/E ratio of -15.81, a PEG ratio of 1.74 and a beta of 1.06. Cronos Group Inc. has a one year low of $1.60 and a one year high of $3.14. The stock's fifty day moving average price is $1.82 and its 200-day moving average price is $1.94.
Cronos Group (NASDAQ:CRON - Get Free Report) last announced its quarterly earnings data on Thursday, May 8th. The company reported $0.02 earnings per share for the quarter, beating the consensus estimate of $0.01 by $0.01. The firm had revenue of $33.62 million during the quarter, compared to analyst estimates of $45.44 million. Cronos Group had a negative return on equity of 2.56% and a negative net margin of 42.65%. As a group, sell-side analysts forecast that Cronos Group Inc. will post -0.03 earnings per share for the current year.
Cronos Group Company Profile
(
Free Report)
Cronos Group Inc operates as a cannabinoid company that engages in the cultivation, production and marketing of cannabis products in Canada, Israel, and Germany. It offers dried flower, pre-rolls, oils, vaporizers, edibles, and cannabis tinctures under the Spinach, Lord Jones, and PEACE NATURALS brands.
Read More
Before you consider Cronos Group, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Cronos Group wasn't on the list.
While Cronos Group currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Learn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
